Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murakami, A.
Right arrow Articles by Ohigashi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murakami, A.
Right arrow Articles by Ohigashi, H.
[Cancer Research 60, 5059-5066, September 15, 2000]
© 2000 American Association for Cancer Research


Carcinogenesis

Inhibitory Effect of Citrus Nobiletin on Phorbol Ester-induced Skin Inflammation, Oxidative Stress, and Tumor Promotion in Mice1

Akira Murakami, Yoshimasa Nakamura, Koji Torikai, Takuji Tanaka, Teruaki Koshiba, Koichi Koshimizu, Shigeru Kuwahara, Yasuo Takahashi, Kazunori Ogawa, Masamichi Yano, Harukuni Tokuda, Hoyoku Nishino, Yoshihiro Mimaki, Yutaka Sashida, Susumu Kitanaka and Hajime Ohigashi2

Department of Biotechnological Science, Faculty of Biology-Oriented Science and Technology, Kinki University, Wakayama 649-6493 [A. M., T. K., K. K.]; Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502 [Y. N., K. T., H. O.]; First Department of Pathology, Kanazawa Medical University, Ishikawa 920-0293 [T. T.]; Research and Development Division, Wakayama Agricultural Processing Research Corporation, Nagagun, Wakayama 649-6112 [S. K., Y. T.]; Department of Citriculture, Fruit Tree Research Station, Shizuoka 424-0292 [K. O., M. Y.]; Department of Biochemistry, Kyoto Prefecture University of Medicine, Kyoto 602-0841 [H. T., H. N.]; Laboratory of Medicinal Plant Science, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Tokyo 192-0392 [Y. M., Y. S.]; and Laboratory of Pharmacognosy, College of Pharmacy, Nihon University Chiba 274–8555 [S. K.], Japan

The intake of citrus fruits has been suggested as a way to prevent the development of some types of human cancer. Nitric oxide (NO) is closely associated with the processes of epithelial carcinogenesis. We attempted a search for NO generation inhibitors in Citrus unshiu. The active constituent was traced by an activity-guiding separation. NO and superoxide (O2-) generation was induced by a combination of lipopolysaccharide and IFN-{gamma} in mouse macrophage RAW 264.7 cells, and by 12-O-tetradecanoylphorbol-13-acetate (TPA) in differentiated human promyelocyte HL-60, respectively. Expression of inducible NO synthase and cyclooxygenase 2 proteins were detected by Western blotting. The in vivo anti-inflammatory and antitumor promoting activities were evaluated by topical TPA application to ICR mouse skin with measurement of edema formation, epidermal thickness, leukocyte infiltration, hydrogen peroxide production, and the rate of proliferating cell nuclear antigen-stained cells. As a result, nobiletin, a polymethoxyflavonoid, was identified as an inhibitor of both NO and O2- generation. Nobiletin significantly inhibited two distinct stages of skin inflammation induced by double TPA application [first stage priming (leukocyte infiltration) and second stage activation (oxidative insult by leukocytes)] by decreasing the inflammatory parameters. It also suppressed the expression of cyclooxygenase-2 and inducible NO synthase proteins and prostaglandin E2 release. Nobiletin inhibited dimethylbenz[a]anthracene (0.19 µmol)/TPA (1.6 nmol)-induced skin tumor formation at doses of 160 and 320 nmol by reducing the number of tumors per mouse by 61.2% (P < 0.001) and 75.7% (P < 0.001), respectively. The present study suggests that nobiletin is a functionally novel and possible chemopreventive agent in inflammation-associated tumorigenesis.




This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
S. Rahman, R. A. Ansari, H. Rehman, S. Parvez, and S. Raisuddin
Nordihydroguaiaretic Acid from Creosote Bush (Larrea tridentata) Mitigates 12-O-Tetradecanoylphorbol-13-Acetate-induced Inflammatory and Oxidative Stress Responses of Tumor Promotion Cascade in Mouse Skin
Evid. Based Complement. Altern. Med., October 27, 2009; (2009) nep076v1.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Yasuda, T. Nishizawa, H. Ohigashi, T. Tanaka, D.-X. Hou, N. H. Colburn, and A. Murakami
Linoleic acid metabolite suppresses skin inflammation and tumor promotion in mice: possible roles of programmed cell death 4 induction
Carcinogenesis, July 1, 2009; 30(7): 1209 - 1216.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-S. Lai, S. Li, C.-Y. Chai, C.-Y. Lo, S. Dushenkov, C.-T. Ho, M.-H. Pan, and Y.-J. Wang
Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3',4'-didemethylnobiletin, derived from nobiletin
Carcinogenesis, December 1, 2008; 29(12): 2415 - 2424.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Onozuka, A. Nakajima, K. Matsuzaki, R.-W. Shin, K. Ogino, D. Saigusa, N. Tetsu, A. Yokosuka, Y. Sashida, Y. Mimaki, et al.
Nobiletin, a Citrus Flavonoid, Improves Memory Impairment and A{beta} Pathology in a Transgenic Mouse Model of Alzheimer's Disease
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 739 - 744.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Miyamoto, Y. Yasui, T. Tanaka, H. Ohigashi, and A. Murakami
Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice
Carcinogenesis, May 1, 2008; 29(5): 1057 - 1063.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-S. Lai, S. Li, C.-Y. Chai, C.-Y. Lo, C.-T. Ho, Y.-J. Wang, and M.-H. Pan
Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice
Carcinogenesis, December 1, 2007; 28(12): 2581 - 2588.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
K. P. Datla, V. Zbarsky, D. Rai, S. Parkar, N. Osakabe, O. I. Aruoma, and D. T. Dexter
Short-Term Supplementation with Plant Extracts Rich in Flavonoids Protect Nigrostriatal Dopaminergic Neurons in a Rat Model of Parkinson's Disease
J. Am. Coll. Nutr., August 1, 2007; 26(4): 341 - 349.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Y. Chung, J. H. Park, M. J. Kim, H. O. Kim, J. K. Hwang, S. K. Lee, and K. K. Park
Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-{kappa}B
Carcinogenesis, June 1, 2007; 28(6): 1224 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. J. Roberts, B. Y. Ng, R. B. Filler, J. Lewis, E. J. Glusac, A. C. Hayday, R. E. Tigelaar, and M. Girardi
Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis
PNAS, April 17, 2007; 104(16): 6770 - 6775.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Murakami, T. Shigemori, and H. Ohigashi
Zingiberaceous and Citrus Constituents, 1'-Acetoxychavicol Acetate, Zerumbone, Auraptene, and Nobiletin, Suppress Lipopolysaccharide-Induced Cyclooxygenase-2 Expression in RAW264.7 Murine Macrophages through Different Modes of Action
J. Nutr., December 1, 2005; 135(12): 2987S - 2992S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. M. Sung, G. He, and S. M. Fischer
Lack of Expression of the EP2 but not EP3 Receptor for Prostaglandin E2 Results in Suppression of Skin Tumor Development
Cancer Res., October 15, 2005; 65(20): 9304 - 9311.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. Osakabe, A. Yasuda, M. Natsume, and T. Yoshikawa
Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model
Carcinogenesis, April 1, 2004; 25(4): 549 - 557.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Naasani, F. Oh-hashi, T. Oh-hara, W. Y. Feng, J. Johnston, K. Chan, and T. Tsuruo
Blocking Telomerase by Dietary Polyphenols Is a Major Mechanism for Limiting the Growth of Human Cancer Cells in Vitro and in Vivo
Cancer Res., February 15, 2003; 63(4): 824 - 830.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. W. Kim, A. Murakami, M. V. Williams, and H. Ohigashi
Mutagenicity of reactive oxygen and nitrogen species as detected by co-culture of activated inflammatory leukocytes and AS52 cells
Carcinogenesis, February 1, 2003; 24(2): 235 - 241.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.-H. Pan, W.-J. Chen, S.-Y. Lin-Shiau, C.-T. Ho, and J.-K. Lin
Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells
Carcinogenesis, October 1, 2002; 23(10): 1677 - 1684.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Sato, L. Koike, Y. Miyata, M. Hirata, Y. Mimaki, Y. Sashida, M. Yano, and A. Ito
Inhibition of Activator Protein-1 Binding Activity and Phosphatidylinositol 3-Kinase Pathway by Nobiletin, a Polymethoxy Flavonoid, Results in Augmentation of Tissue Inhibitor of Metalloproteinases-1 Production and Suppression of Production of Matrix Metalloproteinases-1 and -9 in Human Fibrosarcoma HT-1080 Cells
Cancer Res., February 1, 2002; 62(4): 1025 - 1029.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Nakamura, Q. Feng, T. Kumagai, K. Torikai, H. Ohigashi, T. Osawa, N. Noguchi, E. Niki, and K. Uchida
Ebselen, a Glutathione Peroxidase Mimetic Seleno-organic Compound, as a Multifunctional Antioxidant. IMPLICATION FOR INFLAMMATION-ASSOCIATED CARCINOGENESIS
J. Biol. Chem., January 18, 2002; 277(4): 2687 - 2694.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.